534 Results for "

MCF7 cells

" in MedChemExpress (MCE) Product Catalog:
Products (534)

534 Results for "MCF7 cells" in MCE Product Catalog:

Cat. No.: HY-148453
CAS No.: 15641-17-5
Purity:  99.25%
Target:  

Drug Derivative

Research Areas:  

Cancer

Antiproliferative agent-16 is an indolyl hydrazide-hydrazone compound with anticancer activity. Antiproliferative agent-16 exhibits specificity toward breast cancer cells (IC50 of 6.94 μM for MCF-7 cells) .
loading...
    loading...
Cat. No.: HY-170402
CAS No.: 3075160-74-3
Target:  

Sirtuin Apoptosis

Research Areas:  

Cancer

SIRT6-IN-4 (Compound 10d) is a selective inhibitor for SIRT6 with an IC50 of 5.68 μM. SIRT6-IN-4 inhibits the proliferation of MCF-7 with an IC50 of 8.30 μM. SIRT6-IN-4 arrests the cell cycle at G2/M phase, inhibits thecell migration and invasion of MCF-7, and induces apoptosis. SIRT6-IN-4 exhibits antitumor efficacy in mouse models .
loading...
    loading...
Cat. No.: HY-178774
CAS No.: 1430798-23-4
Synonyms: Isopentyl-deoxynboquinone
Target:  

Quinone Reductase

Research Areas:  

Cancer

IP-DNQ is an efficient NQO1 dependent cytotoxic agent. IP-DNQ has a potent killing effect on MCF-7 cells (IC50 = 0.18 µM). IP-DNQ can be used for cancer research .
loading...
    loading...
Cat. No.: HY-107550
CAS No.: 956154-63-5
Target:  

HDAC

Research Areas:  

Cancer

NCT-14b is a HDAC6-selective inhibitor. NCT-14b blocks the growth of estrogen receptor α-positive breast cancer MCF-7 cells .
loading...
    loading...
Cat. No.: HY-135590
CAS No.: 185415-07-0
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology

Raloxifene 4-Monomethyl Ether (Compound 37) is a Raloxifene derivative that inhibits estrogen receptor α. Raloxifene 4-Monomethyl Ether inhibits MCF-7 cells with an IC50 of 1 μM and a pIC50 of 6 .
loading...
    loading...
Cat. No.: HY-W288480
CAS No.: 2528-39-4
Target:  

Apoptosis

Research Areas:  

Cancer

Trihexyl phosphate is an organophosphate flame retardant. Trihexyl phosphate causes mitochondrial impairment and induces cell apoptosis in CHO cells. Trihexyl phosphate promotes the proliferation of human breast cancer cells (MCF-7) in a dose-dependent manner and exerts estrogenicity via ERα-independent pathways .
loading...
    loading...
Cat. No.: HY-178099
Research Areas:  

Cancer

Apoptosis inducer 45 is an apoptosis inducer. Apoptosis inducer 45 is cytotoxically active against the MCF-7 cell line. Apoptosis inducer 45 elicits MCF-7 cell apoptosis via the mitochondrial pathway (increases the Bax/Bcl-2 ratio) by activating cleavage of caspase-9, thereby inducing the fragmentation of DNA repair protein PARP. Apoptosis inducer 45 also can induce caspase-8 cleavage, subsequently initiating cleavage of caspase-3 and its downstream protein PARP to culminate in the extrinsic apoptosis. Apoptosis inducer 45 can be used in the research of breast cancer .
loading...
    loading...
Cat. No.: HY-153700
CAS No.: 2170766-56-8
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Estrogen receptor modulator 8 (Compound 4) down-regulates estrogen receptor with an IC50 of 0.1 nM-10 nM. Estrogen receptor modulator 8 degrades ERα (IC50: 25.7 nM in vitro, 0.136 nM in MCF-7 cell). Estrogen receptor modulator 8 also inhibits MCF-7 cell growth (IC50: 0.1 nM), and MCF-7 tumor growth .
loading...
    loading...
Cat. No.: HY-169122
Target:  

Drug Derivative

Research Areas:  

Cancer

LLC1 is an Amiloride (HY-B0285) derivative with cytotoxicity against breast cancer cells, particularly those resistant to treatment. The IC50 values of LLC1 for MCF7, MCF7 MX-100, MCF7 TS, MCF7 TR-1, and MCF7 TR-5 are 13, 12, 25, 26, and 19 mM, respectively. LLC1 shows potential for research in the field of cancer therapy .
loading...
    loading...
Cat. No.: HY-N11973
CAS No.: 42050-16-8
5,7-Dimethoxy-2,3-phenanthrenediol is a compound with estrogenic activity. 5,7-Dimethoxy-2,3-phenanthrenediol increases the proliferation of MCF-7 cell and the expression of ERβ in the MCF-7 cell line .
loading...
    loading...
Cat. No.: HY-144637
CAS No.: 2684238-37-5
Target:  

Apoptosis Autophagy

Research Areas:  

Cancer

Autophagy inducer 2 (Compound 11i) is a potent autophagy inducer. Autophagy inducer 2 exhibits apparent antiproliferative activity against the MCF-7 cell line with an IC50 value of 1.31 μM and remarkably inhibits the colony formation of the MCF-7 cells. Autophagy inducer 2 arrests the MCF-7 cells in the G2/M phase by regulating the cell-cycle-related proteins Cdk-1 and Cyclin B1. Autophagy inducer 2 has the potential for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-161858
Target:  

PI3K Akt Apoptosis

Research Areas:  

Cancer

EpskA21 is an inhibitor for PI3K/AKT signaling pathway, and inhibits the proliferation of cancer cells MCF-7, A549, MIA-PaCa-2, Panc-1 and HepG2, with IC50 of 1.3-7.24 μM. EpskA21 inhibits the cell migration, arrests the cell cycle at G2/M (MCF-7) and S (MIA-PaCa-2) phase, and induces apoptosis in MCF-7 and MIA-PaCa-2. EpskA21 causes the mitochondrial dysfunction .
loading...
    loading...
Cat. No.: HY-144306
CAS No.: 2763464-53-3
Research Areas:  

Cancer

ERα degrader 4 is an excellent and selective estrogen receptor α (ERα) degrader (IC50 of 0.31, 0.41 and 0.48 μM in MDA-MB-231, MCF-7 and MCF-7/ADR cells, respectively). ERα degrader 4 has potent inhibitory activity against MCF-7 cell lines. ERα degrader 4 is a potential SERDs candidate for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-170590
Research Areas:  

Cancer

VEGFR-2-IN-61 (Compound 7b) is an inhibitor for VEGFR-2 with an IC50 of 2.83 µM. VEGFR-2-IN-61 inhibits the proliferation of multi cancer cells (IC50 for MCF-7 is 2.12 μM). VEGFR-2-IN-61 inhibits the cell migration, induces oxidative stress and apoptosis in MCF-7 .
loading...
    loading...
Cat. No.: HY-155841
Research Areas:  

Cancer

Tubulin polymerization-IN-46 (compound 9q) is a microtubule/Tubulin inhibitor that inhibits tubulin polymerization and induces apoptosis. Tubulin polymerization-IN-46 inhibits mitosis and arrests MCF-7 cells in the G2/M phase. Tubulin polymerization-IN-46 has anti-proliferative activity against MCF-7 breast cancer cells with an IC50 of 10 nM .
loading...
    loading...
Cat. No.: HY-147967
CAS No.: 2414635-72-4
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-63 is an EGFR inhibition (IC50: 0.096 μM) and it has anticancer activity in MCF-7 cells (IC50: 2.49 μM).
loading...
    loading...
Cat. No.: HY-N14603
CAS No.: 664355-12-8
Chandrananimycin A has anti-mucor activity, as well as anti-tumor cell activity such as CCL HT29, MFXF 529L, MACL McF-7 .
loading...
    loading...
Cat. No.: HY-N3042
CAS No.: 41137-85-3
Synonyms: Platyphyllone
Platyphyllonol (Platyphyllone) can be isolated from A. japonica. Platyphyllonol shows cytotoxic effects on MCF-7 cells with IC50 values of 46.9 μg/mL .
loading...
    loading...
Cat. No.: HY-163126
CAS No.: 2214210-63-4
Target:  

Cholinesterase (ChE)

Research Areas:  

Cancer

AChE-IN-52 (compound A6) is an acetylcholinesterase (AChE) inhibitor. AChE-IN-52 shows antitumor efficacy, especially against breast cancer MCF-7 cells. AChE-IN-52 significantly disrupts the amino acid metabolism and inhibits migration of MCF-7. AChE-IN-52 plays anticancer role by regulating Best1 and HIST1H2BJ .
loading...
    loading...
Cat. No.: HY-158387
CAS No.: 2916404-95-8
Target:  

Topoisomerase

Research Areas:  

Cancer

Anticancer agent 214 (2) is a Camptothecin compound, with IC50 values of 2.6 nM and 15.7 nM in MCF-7 cells and MDA-MB-231 cells, respectively .
loading...
    loading...